8-K: Edgewell Personal Care Reports Mixed Q1 Results, Maintains Full Year Outlook

Sentiment:

Quarterly Report


Edgewell Personal Care saw a 4.2% increase in net sales in the first quarter of fiscal year 2024, driven by international growth, but experienced a decline in earnings per share.

Worse than expectedThe company's GAAP and adjusted EPS decreased compared to the prior year quarter, indicating a decline in profitability.The adjusted operating margin decreased, primarily due to higher marketing and SG&A expenses.

Summary

  • Edgewell Personal Care's net sales for the first quarter of fiscal year 2024 reached $488.9 million, a 4.2% increase compared to the same period last year.
  • Organic net sales, which exclude currency impacts, grew by 3.1%, primarily due to strong international performance.
  • GAAP diluted earnings per share (EPS) decreased to $0.09 from $0.24 in the prior year quarter, while adjusted EPS fell to $0.24 from $0.32.
  • The company ended the quarter with $214.2 million in cash and access to a $206.6 million revolving credit facility, with a net debt leverage ratio of 3.8x.
  • Edgewell returned $22.6 million to shareholders through share repurchases ($15.0 million) and dividends ($7.6 million).
  • The company's full-year outlook remains unchanged, with expected net sales growth of 1% to 3% and organic net sales growth of 2% to 4%.

Sentiment

Score: 5

Explanation: The document presents a mixed picture with positive sales growth offset by declining earnings and increased costs. The company maintains its outlook, but the overall sentiment is neutral to slightly negative due to the earnings decline.

Positives

  • The company experienced strong organic net sales growth of 3.1%, driven by international markets.
  • Gross margin exceeded expectations due to productivity savings and improved revenue management.
  • The Wet Shave segment showed significant growth, with net sales up 9.6% and organic net sales up 8.1%.
  • The company maintained its full-year outlook, indicating confidence in future performance.
  • Shareholder returns were strong with $22.6 million returned through share repurchases and dividends.

Negatives

  • GAAP diluted EPS decreased to $0.09 from $0.24 in the prior year quarter.
  • Adjusted EPS decreased to $0.24 from $0.32 in the prior year quarter.
  • Adjusted operating margin decreased by 70 basis points, or 150 basis points in constant currency, primarily due to higher marketing and SG&A expenses.
  • Feminine Care segment net sales decreased by 11.2%, driven by a decline in Tampons.
  • Sun and Skin segment profit decreased by $14.6 million, primarily due to higher inflation related costs.

Risks

  • The company faces challenges from core gross inflationary pressures and transitory cost headwinds.
  • The Feminine Care segment experienced a significant decline in sales, particularly in tampons.
  • The Sun and Skin Care segment saw a decrease in profit due to higher inflation related costs.
  • The company is undergoing restructuring and re-positioning actions, which may incur pre-tax charges of approximately $19 million for the full fiscal year.
  • The company's adjusted EPS outlook includes an estimated $0.20 unfavorable impact from foreign currency movements.

Future Outlook

The company maintains its full-year outlook, expecting net sales to increase by 1% to 3% and organic net sales to increase by 2% to 4%. Adjusted EPS is expected to be in the range of $2.65 to $2.85, and adjusted EBITDA is expected to be in the range of $340 to $352 million. Approximately 65% of adjusted earnings are expected to be generated in the second half of the fiscal year.

Management Comments

  • We had a good start to the fiscal year, with 3% organic net sales growth, and notably strong performance across our international markets, reflective of underlying volume growth and further price execution.
  • Gross margin was a highlight and above our expectations, driven by our ability to realize further productivity savings and gains from improved revenue management.
  • With this good start and strong fundamentals in place, we are on track to meet our previous outlook for both top and bottom line.
  • Our performance reflects the changes we've implemented across our organization, leading to more consistent organic net sales growth, better operational execution, continued efficiency in our supply chain, and increased brand investment behind our strategic priorities.
  • We believe continued focus on our strategic priorities and strong execution positions us to deliver significant value creation for our shareholders.

Industry Context

The results reflect a mixed performance in the consumer goods sector, with strong international growth offset by challenges in specific product categories and increased costs. The company's focus on productivity and strategic priorities aligns with industry trends towards efficiency and brand investment.

Comparison to Industry Standards

  • Edgewell's 3.1% organic net sales growth is moderate compared to some high-growth consumer product companies, but it is a positive sign given the current economic environment.
  • The adjusted gross margin increase of 30 basis points is a positive development, but the company needs to continue to focus on cost management to improve profitability.
  • The decline in the Feminine Care segment is concerning and may indicate a need for strategic adjustments in that area.
  • Compared to competitors like Procter & Gamble and Unilever, Edgewell's growth is more modest, but the company is focused on specific segments and international markets where it has a competitive advantage.
  • The company's net debt leverage ratio of 3.8x is within acceptable limits for the industry, but it is important to monitor this metric going forward.

Stakeholder Impact

  • Shareholders will see a decrease in earnings per share, but will receive dividends and benefit from share repurchases.
  • Employees may be impacted by restructuring and re-positioning actions.
  • Customers may see changes in product offerings and pricing.
  • Suppliers may be impacted by changes in the company's supply chain.

Next Steps

  • The company will continue to focus on its strategic priorities and operational execution.
  • The company will hold an investor conference call to discuss the results.
  • The company will continue to monitor and manage its cost structure.
  • The company will continue to execute share repurchases under the 2018 authorization.

Key Dates

DateDescription
February 1, 2024The company held its Annual Meeting of Shareholders and the Board of Directors declared a quarterly cash dividend.
February 7, 2024Edgewell Personal Care Company issued a press release announcing financial and operating results for its first quarter of fiscal 2024.
April 4, 2024The declared cash dividend will be payable to shareholders of record as of March 7, 2024.

Keywords

Edgewell Personal Care, Net Sales, Organic Growth, Earnings Per Share, Gross Margin, Wet Shave, Feminine Care, Sun and Skin Care, Share Repurchases, Dividends, Restructuring, Financial Results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.